By: Charissa On: June 16, 2022 In:

3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

Print Friendly, PDF & Email

Leave reply:

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.